Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis.
Autor: | Fahmy JN; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA. Electronic address: joseph.n.fahmy@luhs.org., Varsanik MA; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Hubbs D; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA., Eguia E; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA., Abood G; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA., Knab LM; Loyola University Medical Center, Department of Surgery, Maywood, IL, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | American journal of surgery [Am J Surg] 2021 Mar; Vol. 221 (3), pp. 529-533. Date of Electronic Publication: 2020 Dec 24. |
DOI: | 10.1016/j.amjsurg.2020.12.037 |
Abstrakt: | Background: Pancreatic neuroendocrine tumors are rare, with rising incidence and limited clinicopathological studies. Methods: Adult patients with pNET at a single tertiary care center were retrospectively evaluated. Results: In total, 87 patients with histologically confirmed pNET who underwent resection were evaluated. 11% of patients had functioning pNETs: 9 insulinoma and 1 VIPoma. The majority (88.5%) were nonfunctioning. The most common surgical procedure performed was distal pancreatectomy with splenectomy (36.8%). 35.6% of cases were performed with minimally invasive surgery (MIS). MIS patients had fewer postoperative complications, shorter length of stay, and fewer ICU admissions.Disease-free survival (DFS) was unaffected by tumor size (p = 0.5) or lymph node status (p = 0.62). Patients with high-grade (G3) tumors experienced significantly shorter DFS (p = 0.02). Conclusions: This series demonstrates that survival in patients with pNET is driven mostly by tumor grade, though overall most have long-term survival after surgical resection. Additionally, an MIS approach is efficacious in appropriately selected cases. Competing Interests: Conflict of interest The authors have no conflicts of interest, financial or otherwise, to disclose. (Copyright © 2020 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |